Biopsy Results Explained: Understanding Your Pathology Report (2026)

Waiting for biopsy results can be an anxious time, but understanding what your pathology report says helps you participate in your care decisions. This guide breaks down common biopsy findings and explains what medical terms on your report mean.

<ClinicalSpotlight urgency="varies" prevalence="Over 1 million biopsies performed annually in the US; 80-85% are benign (non-cancerous); Proper interpretation guides treatment decisions" keyFinding="Understanding biopsy terminology and results empowers patients to comprehend diagnoses, ask informed questions, and participate in treatment planning" />

Understanding the Procedure

What a biopsy is:

• Tissue sampling: Removal of small amount of tissue for examination
• Pathology: Microscopic examination by pathologist
• Diagnosis: Determines if cells are benign, malignant (cancerous), or precancerous
• Types: Needle, surgical, endoscopic, skin, bone marrow

Why biopsies are done:

• Abnormal imaging: Mass, nodule, lesion seen on X-ray, CT, MRI
• Abnormal blood tests: Suggesting certain conditions
• Skin lesions: Moles, rashes, growths
• Organ function: Liver, kidney biopsies to assess disease
• Cancer staging: Determine extent of known cancer

The pathology report:

• Diagnosis: What the abnormality is
• Description: Microscopic appearance
• Additional tests: Special studies performed
• Prognostic information: How the condition behaves
• Treatment guidance: Helps determine appropriate therapy

Report Structure

Standard sections:

Specimen:

• What tissue: Organ, site sampled
• Procedure: How obtained (needle, excisional, etc.)
• Clinical history: Relevant information provided to pathologist

Gross description:

• Macroscopic: What tissue looks like to naked eye
• Size: Dimensions
• Appearance: Color, consistency, abnormalities

Microscopic description:

• Microscopic appearance: What cells look like under microscope
• Cellular features: Size, shape, arrangement
• Additional findings: Inflammation, necrosis, etc.

Diagnosis:

• The bottom line: What the condition is
• Benign vs. malignant: Cancerous or not
• Specific type: If abnormal

Special studies (if done):

• Immunohistochemistry: Special stains to identify cell type
• Molecular tests: Genetic analysis
• Hormone receptors: For certain cancers

General Terms

Benign:

• Non-cancerous: Doesn't spread to other parts of body
• May still need treatment: Some benign conditions require removal
• Examples: Lipoma, fibroadenoma, benign prostate hyperplasia

Malignant:

• Cancerous: Can invade nearby tissues, spread (metastasize)
• Requires treatment: Usually surgery, possibly chemotherapy, radiation
• Examples: Carcinoma, sarcoma, melanoma, leukemia

Atypical:

• Not normal: But not clearly malignant either
• Precancerous: May progress to cancer if untreated
• Uncertain behavior: May need complete removal
• Examples: Atypical moles, hyperplasia

Carcinoma:

• Cancer arising: From epithelial cells (lining of organs, skin)
• Most common: Type of cancer
• Examples: Adenocarcinoma, squamous cell carcinoma

Sarcoma:

• Cancer arising: From connective tissue (bone, muscle, fat, cartilage)
• Less common: Than carcinomas
• Examples: Osteosarcoma, liposarcoma

Descriptive Terms

Cellular features:

• Pleomorphism: Variation in cell size and shape (more = more abnormal)
• Hyperchromasia: Darker nuclei (more DNA)
• Mitoses: Cell division (more = more rapidly growing)
• Nuclear atypia: Abnormal appearing nuclei

Growth patterns:

• Infiltrative: Invading into surrounding tissue
• Circumscribed: Well-defined borders
• Encapsulated: Surrounded by capsule (usually benign)

Additional findings:

• Necrosis: Cell death (seen in aggressive tumors)
• Inflammation: Immune cells present
• Fibrosis: Scarring
• Vascular invasion: Tumor in blood vessels (increases metastasis risk)

Common Diagnoses

Actinic keratosis:

• What it is: Precancerous lesion from sun damage
• Appearance: Abnormal keratinocytes
• Significance: May progress to squamous cell carcinoma if untreated
• Treatment: Cryotherapy, topical medications, removal

Basal cell carcinoma:

• What it is: Most common type of skin cancer
• Behavior: Slow-growing, rarely metastasizes
• Treatment: Surgical removal (usually curative)

Squamous cell carcinoma:

• What it is: Skin cancer from squamous cells
• Behavior: Can metastasize (though less common than BCC)
• Treatment: Surgical removal, may need lymph node evaluation

Melanoma:

• What it is: Most serious type of skin cancer
• Behavior: Can metastasize aggressively
• Diagnosis: Based on microscopic appearance, depth (Breslow thickness)
• Treatment: Surgical removal (wide excision), possibly lymph node biopsy, additional therapy

Dysplastic nevus:

• What it is: Atypical mole
• Significance: Increased risk of melanoma
• Behavior: Benign but removed to prevent confusion with melanoma

Seborrheic keratosis:

• What it is: Benign, waxy, stuck-on appearance
• Significance: Harmless, often removed for appearance or diagnosis

Breast Pathology

Fibroadenoma:

• What it is: Benign breast tumor
• Common: In young women
• Behavior: Benign, doesn't progress to cancer
• Treatment: Usually observation, may remove if growing or symptomatic

Fibrocystic changes:

• What it is: Benign breast changes
• Common: In women of reproductive age
• Behavior: Benign, doesn't increase cancer risk significantly
• Treatment: Usually observation, symptom management

Atypical hyperplasia:

• What it is: Overgrowth of abnormal cells
• Significance: Increased breast cancer risk (4-5x)
• Treatment: Usually surgical excision, close monitoring, risk-reduction medications considered

Ductal carcinoma in situ (DCIS):

• What it is: Earliest form of breast cancer (confined to ducts)
• Behavior: Not invasive but may progress to invasive cancer
• Treatment: Surgery (lumpectomy or mastectomy), possibly radiation, hormonal therapy

Invasive ductal carcinoma:

• What it is: Most common type of breast cancer
• Behavior: Invasive (spread beyond ducts), can metastasize
• Treatment: Surgery, radiation, chemotherapy, hormonal therapy as indicated
• Grading: Well, moderately, poorly differentiated
• Hormone receptor status: ER/PR positive or negative
• HER2 status: Positive or negative (affects treatment)

Invasive lobular carcinoma:

• What it is: Second most common type of breast cancer
• Behavior: Invasive, can be more difficult to detect on imaging
• Treatment: Similar to ductal carcinoma

Prostate Pathology

Benign prostate tissue:

• Normal prostate: Glands, stroma appear normal
• Benign prostatic hyperplasia: Enlargement from benign growth
• Inflammation: Prostatitis (may cause elevated PSA)

Prostatic intraepithelial neoplasia (PIN):

• What it is: Precancerous changes
• High-grade PIN: Increased cancer risk
• Management: Close monitoring, repeat biopsy

Atypical small acinar proliferation (ASAP):

• What it is: Abnormal glands not clearly cancerous
• Significance: 40-50% have cancer on repeat biopsy
• Management: Repeat biopsy recommended

Prostate adenocarcinoma:

• What it is: Prostate cancer
• Gleason score: Grade (pattern) + Grade (pattern) = score (2-10)
  • Gleason 6: Low grade, slow-growing
  • Gleason 7: Intermediate grade
  • Gleason 8-10: High grade, aggressive
• Grading: Well, moderately, poorly differentiated
• Treatment: Active surveillance (low grade), surgery, radiation, hormonal therapy

Liver Pathology

Normal liver:

• Architecture: Normal lobular architecture
• Hepatocytes: Normal appearance
• No fibrosis: No scarring
• No inflammation: No significant inflammatory cells

Fatty liver (steatosis):

• What it is: Fat accumulation in hepatocytes
• Grading: Mild, moderate, severe based on amount of fat
• Causes: Obesity, diabetes, alcohol, medications
• Significance: Can progress to steatohepatitis, cirrhosis
• Treatment: Weight loss, management of underlying conditions

Steatohepatitis:

• What it is: Fatty liver with inflammation and cell damage
• NASH: Non-alcoholic steatohepatitis
• ASH: Alcoholic steatohepatitis
• Significance: Can progress to cirrhosis
• Treatment: Address underlying cause (weight loss, alcohol cessation)

Fibrosis:

• What it is: Scarring of liver
• Staging: Stage 0 (none) to Stage 4 (cirrhosis)
• Causes: Chronic hepatitis, alcohol, NASH, many other liver diseases
• Significance: Progressive if underlying cause not treated
• Treatment: Treat underlying cause, monitor for progression

Cirrhosis:

• What it is: End-stage scarring of liver
• Appearance: Nodular regeneration, fibrosis, architectural distortion
• Significance: Liver failure, portal hypertension, increased liver cancer risk
• Treatment: Manage complications, consider transplant

Hepatitis:

• Inflammatory: Infiltration by inflammatory cells
• Causes: Viral (hepatitis B, C), autoimmune, drug-induced
• Grading: Mild, moderate, severe based on amount of inflammation
• Treatment: Depends on cause (antivirals, immunosuppressants, stop offending drug)

Hepatocellular carcinoma:

• What it is: Primary liver cancer
• Risk: Cirrhosis, hepatitis B or C
• Appearance: Malignant hepatocytes
• Treatment: Surgery, transplant, ablation, embolization, targeted therapy

Gastrointestinal Pathology

Normal colon mucosa:

• Appearance: Normal glands, no inflammation
• No abnormal findings: Healthy

Adenomatous polyp (adenoma):

• What it is: Precancerous growth
• Significance: Can progress to colon cancer
• Villous features: Tubular, tubulovillous, villous (villous higher risk)
• Dysplasia: Low-grade, high-grade (higher risk of cancer)
• Treatment: Polypectomy (removal) during colonoscopy

Hyperplastic polyp:

• What it is: Benign growth
• Significance: No cancer risk
• Treatment: Usually removed during colonoscopy (but not for cancer prevention)

Inflammatory bowel disease:

• Crohn's disease: Patchy inflammation, granulomas
• Ulcerative colitis: Continuous inflammation, crypt distortion
• Dysplasia: Precancerous changes (requires surgery)
• Cancer risk: Increased with long-standing disease

Colorectal adenocarcinoma:

• What it is: Colon cancer
• Staging: Depth of invasion, lymph node involvement
• Grading: Well, moderately, poorly differentiated
• Treatment: Surgery, chemotherapy, radiation (for rectal cancer)

Key Components

Type of cancer:

• Histology: Cell type (adenocarcinoma, squamous cell carcinoma, etc.)
• Site of origin: Where cancer started
• Behavior: Aggressive, indolent (slow-growing)

Grade:

• Well differentiated: Low grade, less aggressive
• Moderately differentiated: Intermediate grade
• Poorly differentiated: High grade, more aggressive
• Undifferentiated: Very aggressive, difficult to determine cell type

Stage:

• Based on: Tumor size, lymph node involvement, metastasis (TNM)
• Stage I: Early, localized
• Stage II: Larger or deeper invasion
• Stage III: Lymph node involvement
• Stage IV: Metastatic (spread to distant organs)

Prognostic factors:

• Grade: Higher grade = worse prognosis
• Stage: Higher stage = worse prognosis
• Lymphovascular invasion: Tumor in lymph/blood vessels = worse prognosis
• Margins: Positive margins (tumor at cut edge) = need additional treatment

Predictive factors (guide treatment):

• Hormone receptors: ER/PR in breast cancer (predicts response to hormonal therapy)
• HER2: In breast cancer (predicts response to targeted therapy)
• EGFR: In lung cancer (predicts response to targeted therapy)
• PD-L1: Predicts response to immunotherapy

Additional Testing

Immunohistochemistry (IHC):

• What it is: Special stains to identify specific proteins
• Purpose: Determine cell type, guide treatment
• Examples: ER/PR/HER2 in breast cancer, PSA in prostate cancer

Molecular testing:

• What it is: Genetic analysis of tumor
• Purpose: Identify mutations, guide targeted therapy
• Examples: EGFR, ALK, BRAF, KRAS mutations

Hormone receptor testing:

• What it is: Test for hormone sensitivity
• Examples: Estrogen/progesterone receptors in breast cancer
• Purpose: Guide hormonal therapy

What Different Diagnoses Mean

Benign diagnosis:

• Good news: Not cancer
• May still need: Treatment or monitoring depending on condition
• Follow-up: May be recommended

Atypical/Precancerous:

• Warning sign: Changes that may progress to cancer
• Usually need: Complete removal, close monitoring
• Discuss: With your doctor about appropriate follow-up

Malignant diagnosis:

• Cancer: Requires treatment
• Next steps: Staging studies (CT, MRI, PET), referral to oncologist
• Comprehensive: Treatment plan involves multiple specialists

Inconclusive:

• Can't determine: Benign vs. malignant
• May need: Additional biopsy, special studies, expert consultation
• Don't panic: Inconclusive is not a diagnosis of cancer

About your diagnosis:

• "What is my diagnosis?"
• "Is it benign or malignant?"
• "What type of [condition] is it?"
• "How certain are you of the diagnosis?"

About staging and treatment:

• "What is the stage?"
• "What are my treatment options?"
• "What do you recommend and why?"
• "What is the prognosis?"
• "Do I need additional tests?"

About second opinions:

• "Can I get a second opinion on my pathology?"
• "Is there an academic center with expertise in this?"
• "Should my biopsy be reviewed by a specialist?"

Understanding your biopsy report empowers you to participate in your care decisions. The diagnosis on the report is the key finding—focus on that section first. Most biopsies are benign, but even when cancer is diagnosed, effective treatments exist.

Key takeaways:

• Biopsy is tissue sampling: For microscopic examination
• Pathology report: Provides diagnosis and detailed information
• Benign: Non-cancerous, most biopsies are benign
• Malignant: Cancerous, requires treatment
• Atypical: Precancerous, may need removal or monitoring
• Special studies: IHC, molecular tests guide treatment
• Staging: Determines extent of disease
• Second opinion: Always appropriate for cancer diagnosis
• Comprehensive care: Multidisciplinary team approach

Remember: Your pathology report is written for your healthcare provider, but understanding the terminology helps you participate in your care. The diagnosis is the most important part—focus on that first. When cancer is diagnosed, comprehensive staging and treatment planning follow. You're not alone—your healthcare team guides you through diagnosis, treatment, and follow-up. Ask questions, seek second opinions, and be an active participant in your care.

Action steps:

1. Review the diagnosis: The bottom line
2. Write down questions: About terms you don't understand
3. Ask about staging: If cancer diagnosed
4. Request copies: Of reports for your records
5. Consider second opinion: Especially for cancer diagnosis
6. Discuss treatment: With specialist(s)
7. Bring support: Family member or friend to appointments
8. Take notes: During discussions with healthcare team

Your biopsy results guide your care journey. Understanding them empowers you to make informed decisions and participate actively in your healthcare.

Sources & Further Reading:

• College of American Pathologists. How to Read Your Pathology Report
• American Cancer Society. Understanding Your Pathology Report
• Journal of Clinical Oncology. Pathology Reports and Treatment Planning
• Archives of Pathology & Laboratory Medicine. Biopsy Interpretation